Related Experiment Video
Updated: Jun 9, 2025
09:02
Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population
Published on: January 31, 2025
415
An Update on the Fracture Risk Assessment Tool: What Have We Learned over 15+ years?
Laura T Dickens1, Rajesh K Jain1
1Department of Medicine, Section of Endocrinology, Diabetes, and Metabolism, The University of Chicago, 5841 South Maryland Avenue, MC 1027, Chicago, IL 60637, USA.
Endocrinology and Metabolism Clinics of North America
|October 24, 2024
Summary
The Fracture Risk Assessment Tool (FRAX) estimates 10-year fracture risk but omits factors like diabetes and falls. Updates are planned to improve its accuracy in predicting bone fractures.
Area of Science:
- Gerontology
- Orthopedics
- Public Health
Background:
- The Fracture Risk Assessment Tool (FRAX) is widely used for 10-year fracture risk prediction.
- FRAX is integrated into clinical guidelines and validated for conditions like chronic kidney disease.
- Limitations include uncaptured risk factors (e.g., diabetes, falls) and controversy over race-ethnicity inclusion.
Purpose of the Study:
- To evaluate the current utility and limitations of the FRAX tool.
- To discuss ongoing developments and potential improvements for fracture risk assessment.
Main Methods:
- Review of existing literature and clinical data on FRAX validation and application.
- Analysis of factors not included in the current FRAX algorithm.
- Consideration of controversies surrounding FRAX's risk variables.
Main Results:
- FRAX is a validated tool but has acknowledged limitations.
- Diabetes and falls are significant risk factors not currently incorporated.
- The role of race-ethnicity in FRAX remains a contentious issue.
Conclusions:
- FRAX remains a valuable tool but requires updates to enhance predictive accuracy.
- Future iterations of FRAX aim to incorporate additional risk factors.
- Refinement of FRAX is crucial for optimizing osteoporosis management and fracture prevention strategies.
